Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.
Merlin
Federica
F
Prochilo
Tiziana
T
Kildani
Basem
B
Tucci
Alessandra
A
Ferrari
Samantha
S
Rossi
Giuseppe
G
D'Adda
Paolo
P
Beretta
Giordano Domenico
GD
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002543:Cerebral Hemorrhage / Q000209:etiology; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000150:complications; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced* / Q000150:complications; D012811:Sigmoid Neoplasms / Q000188:drug therapy* / Q000601:surgery
D018906:Antineoplastic Agents, Alkylating; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil